P2
VC

Paladin Capital Group April 21

United Statespaladincapital.com

Paladin Capital Group April 21 is a venture capital firm based in the United States, investing in Healthcare & Life Sciences, Life Sciences and Cell Therapy, 3 tracked investments.

3
Investments Tracked

About Paladin Capital Group April 21

Paladin Capital Group April 21 is a venture capital firm based in the United States. Brouky tracks 3 investments associated with the firm.

Paladin Capital Group April 21 invests across Healthcare & Life Sciences, Life Sciences, Cell Therapy and Clinical Diagnostics. Coverage extends to 8 sectors in total. Investments are concentrated at Series A.

Paladin Capital Group invests primarily in innovative cybersecurity, defense, and technology companies serving commercial and government markets. They focus on growth-stage ventures that deliver critical technologies to safeguard national security and infrastructure.

Investment Focus

Stage Focus
series-a
Sectors
Healthcare & Life Scienceslife sciencescell therapyclinical diagnosticsgene therapylaboratory-toolsdiagnosticscell-and-gene-therapy

Investment Thesis

Paladin Capital Group invests primarily in innovative cybersecurity, defense, and technology companies serving commercial and government markets. They focus on growth-stage ventures that deliver critical technologies to safeguard national security and infrastructure.

Team

John J. HillC. Christopher DonatRobert StonerSteven W. AndersenCraig Langston

Explore Paladin Capital Group April 21's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in United States

Other Investors in Healthcare & Life Sciences / Life Sciences